Mohammad Ali Omrani

Department of Physiology and Pharmacology, Western University, London, Ontario, Canada, Canada

Poster(s):

• (A-257) Antimuscarinic Medication Use and Risk of Glaucoma: A Literature Review and Disproportionality Analysis Using FAERS
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-231) β-Blockers and Risk of Neuropsychiatric Adverse Events: An Active-Comparator Restricted Disproportionality on the FAERS
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (C-157) β-Blockers and Risk of Neuropsychiatric Disorders: A Systematic Review and Meta-analysis.
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (C-040) Levetiracetam and the Risk of Thrombocytopenia: Active-comparator restricted disproportionality analysis
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (A-180) Machine Learning Methods for Predicting Adverse Drug Events: A Systematic Review
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (B-189) Representativeness of Vulnerable Populations in Randomized Controlled Trials Evaluating the Efficacy and Safety of SGLT-2 Inhibitors: A Systematic Review and Meta-analysis
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (A-258) Trimethoprim-Sulfamethoxazole (TMP-SMX) and Risk of Hemophagocytic Lymphohistiocytosis (HLH): A Literature Review and Disproportionality Analysis Using Individual Safety Case Reports from FAERS
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET